AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| PGF | Ann: Net Tangible Asset Backing 20 April 2018 | 24/04/18 | 0 | 31 | |||
|
|||||||
| PGF | Ann: Quarterly video update notification - March 2018 | 17/04/18 | 0 | 57 | |||
|
|||||||
| PGF | Ann: Quarterly Investment Manager Report - 31 March 2018 | 17/04/18 | 0 | 45 | |||
|
|||||||
| PGF | Ann: Net Tangible Asset Backing 13 April 2018 | 17/04/18 | 0 | 54 | |||
|
|||||||
| PGF | Ann: Net Tangible Asset Backing 6 April 2018 | 10/04/18 | 0 | 70 | |||
|
|||||||
| PGF | Ann: 31 March 2018 Investment Manager Monthly Commentary | 10/04/18 | 0 | 50 | |||
|
|||||||
| PGF | Ann: Net Tangible Asset Backing 31 March 2018 | 04/04/18 | 0 | 53 | |||
|
|||||||
| PGF | Ann: Appendix 3B - DRP | 29/03/18 | 0 | 58 | |||
|
|||||||
See All Discussions
ASX News